ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,854Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 749

$796K Total Retail Price of All Prescriptions

Rank: 55 out of 749

479 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,498 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 604 518 1 6
SIMVASTATIN 552 468 2 5
AMLODIPINE BESYLATE 529 472 3 1
FUROSEMIDE 476 375 4 2
METFORMIN HCL 311 272 5 22
GABAPENTIN 284 199 6 25
BENAZEPRIL HCL 277 207 7 23
RENVELA 269 165 8 3
GLIPIZIDE 262 204 9 32
DIOVAN 236 192 10 14
METOPROLOL TARTRATE 221 179 11 7
TRAMADOL HCL 213 201 12 47
LEVOTHYROXINE SODIUM 212 189 13 13
NIFEDIPINE ER 186 84 14 21
CARVEDILOL 183 162 15 11
CLONIDINE HCL 177 102 16 15
JANUVIA 159 144 17 33
ATENOLOL 154 108 18 20
ISOSORBIDE MONONITRATE ER 141 118 19 45
LISINOPRIL 131 81 20 4
IBUPROFEN 121 93 21 118
HYDROCODONE-ACETAMINOPHEN 115 92 S3 22 12
WARFARIN SODIUM 114 99 23 31
RENAGEL 114 58 10 23 50
FAMOTIDINE 111 94 25 35
NEXIUM 111 93 25 34
PANTOPRAZOLE SODIUM 109 92 27 30
INSULIN SYRINGE 104 91 28 41
AGGRENOX 100 93 29 238
METOPROLOL SUCCINATE 100 86 29 26
ATORVASTATIN CALCIUM 95 63 31 18
ACETAMINOPHEN-CODEINE 85 61 S3 32 79
DONEPEZIL HCL 80 77 33 55
ZOLPIDEM TARTRATE 79 65 34 24
LOSARTAN POTASSIUM 79 73 34 9
LANTUS 77 55 36 36
CLOPIDOGREL 73 59 37 42
DIGOXIN 68 67 38 95
PLAVIX 66 52 39 56
ALENDRONATE SODIUM 65 57 40 40
HUMULIN 70-30 65 57 40 245
CILOSTAZOL 63 62 42 240
DIOVAN HCT 62 41 43 68
HYDROCHLOROTHIAZIDE 59 54 44 27
HYDRALAZINE HCL 55 45 45 19
GLIMEPIRIDE 54 46 46 61
PRAVASTATIN SODIUM 52 51 47 49
LEVOFLOXACIN 52 46 47 81
AMIODARONE HCL 52 27 47 113
AZITHROMYCIN 51 37 50 65
TERAZOSIN HCL 51 30 50 58
ALLOPURINOL 50 50 52 10
POTASSIUM CHLORIDE 50 50 52 37
CALCIUM ACETATE 50 25 52 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.